RxDoctor Payments Data

Michael Wall, PA

Physician Assistant · Powell, TNNPI 1386794717

Payments from drug & device makers

$1,620in general payments, 2019–2025

Across 99 payments — averaging $16.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$605
  • AbbVie$359
  • Bayer$169
  • Lilly USA, LLC$67
  • Amgen$61
  • Amarin Pharma, Inc.$55
  • plus $304 from 10 others

What the payments were for

  • Food & beverage$1,620100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,620 in reported general payments places this provider in the 75th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$12,002
Medicare patients
31
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$56,852
EliquisApixaban15$10,555
JardianceEmpagliflozin12$8,342
Omeprazole61$958
Atorvastatin Calcium76$801
Celecoxib17$783
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$764
Levothyroxine Sodium43$459
Lisinopril62$423
Cyclobenzaprine Hcl22$372
Gabapentin27$301
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$289
Pantoprazole Sodium20$280
Rosuvastatin Calcium20$267
Famotidine21$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$605$56,85231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Powell

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →